Shopping Cart 0
Cart Subtotal
USD 0

Oxygen Conserving Devices Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4900

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6860

Details

Oxygen therapy is considered the most consistent and efficient treatment for patients suffering from chronic obstructive pulmonary diseases (COPD) and hypercapnic chronic respiratory diseases. Oxygen conserving devices are used for regulating the oxygen flow from the oxygen tank to patients while they are moving and away from homecare settings. For instance, Global oxygen therapy manufacturer CAIRE Inc. launched the SAROS 4000 Oxygen System, a proprietary portable oxygen concentrator designed specifically for military use. The newly-updated, CE-marked SAROS meets the standards for the European Economic Area and comes equipped with CAIRE's proprietary technology, autoSAT, providing the ability to consistently maintain oxygen saturation by adjusting to the patient's respiratory rate and deliver up to 3 liters per minute of oxygen therapy to the user. Further, the growing geriatric population is also a major region that is increasing the chances of chronic respiratory diseases. According to the United States Department of Economic and Social Affairs, globally there were around 727 million people aged 65 years or more in the world in 2020. And this share of the global population aged 65 years or above is expected to increase from 9.3% in 2020 to 16% by 2050. Several advancements in oxygen conserving devices have taken place for making them comfortable and portable for the patients which are fueling the industry's growth.

Moreover, some factors that will obstruct the growth of this market include the lack of skilled laborers such as doctors, nurses, medical professionals, and the lack of standards and protocols. Also, the high cost of medical devices is estimated to slow the growth of these products during the forecast period.

The COVID-19 pandemic has led a positive impact on the oxygen conserving market. During the second wave of the pandemic, many middle-income countries are coping with oxygen deficiencies. For instance, according to Statista in May 2021, India was the country with the highest necessity for oxygen conserving devices across the world and Brazil comes in second place with the requirement of 2,273,133 and 385,249 oxygen cylinders, respectively. The pandemic has created a huge demand for oxygen conserving devices and in that condition, many countries and major key players have helped these countries by providing oxygen supplies and funds. For example, Consumer goods giant Hindustan Unilever provided 4,000 oxygen concentrators to India to help meet the medical oxygen requirement of home-bound patients and hospitals amid the devastating second wave of Covid-19.

Based on Product type, the market is bifurcated into electronic oxygen conserver, pneumatic oxygen conserver, disposable oxygen conserver, and others. The electronic oxygen conserver segment grabbed the major market in 2020 as these products are designed for better patient mobility and conserve O2 flow. It improves the efficiency of O2 delivery and is mostly recommended for patients with higher flow requirements.

Based on indication, the market is bifurcated into chronic bronchitis, emphysema, sleep apnea, and others. The chronic bronchitis segment is expected to record significant growth over the forecast period owing to its high prevalence across the globe. Also, it is a very common COPD disease among the people of the U.S. according to the National Health Interview Survey 2019.

Based on end-user, the market is bifurcated into hospitals & clinics, home care settings, and others. The hospitals & clinics segment grabbed the major market in 2020 as hospitals have every type of infrastructure and facilities to treat chronic respiratory diseases like COPD, Asthma, and also Covid-19. These diseases require oxygen conserving devices for the proper supply of oxygen to the patients.

For a better understanding of the market adoption of the oxygen conserving devices market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for oxygen conserving devices and generated maximum revenue in 2020 owing to the increasing incidences of chronic respiratory diseases and the presence of key companies with robust infrastructures.
READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Oxygen Conserving Devices Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Oxygen Conserving Devices Market

2.1.1 Main Objective of the Global Oxygen Conserving Devices Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER OXYGEN CONSERVING DEVICES INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL OXYGEN CONSERVING DEVICES MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT TYPE

8.1 Electronic Oxygen Conserver

8.2 Pneumatic Oxygen Conserver

8.3 Disposable Oxygen Conserver

8.4 Others

9 MARKET INSIGHTS BY IDENTIFICATION

9.1 Chronic Bronchitis

9.2 Emphysema

9.3 Sleep Apnea

9.4 Others

10 MARKET INSIGHTS BY END-USER

10.1 Hospitals & Clinics

10.2 Home Care

10.3 Others

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA OXYGEN CONSERVING DEVICES MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE OXYGEN CONSERVING DEVICES MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC OXYGEN CONSERVING DEVICES MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 South Korea

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD OXYGEN CONSERVING DEVICES MARKET

12 OXYGEN CONSERVING DEVICES MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 OXYGEN CONSERVING DEVICES MARKET OPPORTUNITIES

17 OXYGEN CONSERVING DEVICES MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Inogen Inc.

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1

19.1.6.2

19.1.7 Recent Developments

19.1.7.1

19.1.7.2

19.1.7.3

19.1.7.4

19.2 Chad Therapeutics

19.3 GCE Group

19.4 Precision Medical, Inc

19.5 DeVilbiss Healthcare

19.6 Medline Industries, Inc.

19.7 GF Health Products

19.8 Inovo, Inc

19.9 Essex Industries

19.10 Krober Medizintechnik

20 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Inogen Inc., Chad Therapeutics, GCE Group, Precision Medical, Inc, DeVilbiss Healthcare, Medline Industries, Inc., GF Health Products, Inovo, Inc, Essex Industries, and Krober Medizintechnik

Company Profile

Company Profile Title

Oxygen therapy is considered the most consistent and efficient treatment for patients suffering from chronic obstructive pulmonary diseases (COPD) and hypercapnic chronic respiratory diseases. Oxygen conserving devices are used for regulating the oxygen flow from the oxygen tank to patients while they are moving and away from homecare settings. For instance, Global oxygen therapy manufacturer CAIRE Inc. launched the SAROS 4000 Oxygen System, a proprietary portable oxygen concentrator designed specifically for military use. The newly-updated, CE-marked SAROS meets the standards for the European Economic Area and comes equipped with CAIRE's proprietary technology, autoSAT, providing the ability to consistently maintain oxygen saturation by adjusting to the patient's respiratory rate and deliver up to 3 liters per minute of oxygen therapy to the user. Further, the growing geriatric population is also a major region that is increasing the chances of chronic respiratory diseases. According to the United States Department of Economic and Social Affairs, globally there were around 727 million people aged 65 years or more in the world in 2020. And this share of the global population aged 65 years or above is expected to increase from 9.3% in 2020 to 16% by 2050. Several advancements in oxygen conserving devices have taken place for making them comfortable and portable for the patients which are fueling the industry's growth.

Moreover, some factors that will obstruct the growth of this market include the lack of skilled laborers such as doctors, nurses, medical professionals, and the lack of standards and protocols. Also, the high cost of medical devices is estimated to slow the growth of these products during the forecast period.

The COVID-19 pandemic has led a positive impact on the oxygen conserving market. During the second wave of the pandemic, many middle-income countries are coping with oxygen deficiencies. For instance, according to Statista in May 2021, India was the country with the highest necessity for oxygen conserving devices across the world and Brazil comes in second place with the requirement of 2,273,133 and 385,249 oxygen cylinders, respectively. The pandemic has created a huge demand for oxygen conserving devices and in that condition, many countries and major key players have helped these countries by providing oxygen supplies and funds. For example, Consumer goods giant Hindustan Unilever provided 4,000 oxygen concentrators to India to help meet the medical oxygen requirement of home-bound patients and hospitals amid the devastating second wave of Covid-19.

Based on Product type, the market is bifurcated into electronic oxygen conserver, pneumatic oxygen conserver, disposable oxygen conserver, and others. The electronic oxygen conserver segment grabbed the major market in 2020 as these products are designed for better patient mobility and conserve O2 flow. It improves the efficiency of O2 delivery and is mostly recommended for patients with higher flow requirements.

Based on indication, the market is bifurcated into chronic bronchitis, emphysema, sleep apnea, and others. The chronic bronchitis segment is expected to record significant growth over the forecast period owing to its high prevalence across the globe. Also, it is a very common COPD disease among the people of the U.S. according to the National Health Interview Survey 2019.

Based on end-user, the market is bifurcated into hospitals & clinics, home care settings, and others. The hospitals & clinics segment grabbed the major market in 2020 as hospitals have every type of infrastructure and facilities to treat chronic respiratory diseases like COPD, Asthma, and also Covid-19. These diseases require oxygen conserving devices for the proper supply of oxygen to the patients.

For a better understanding of the market adoption of the oxygen conserving devices market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for oxygen conserving devices and generated maximum revenue in 2020 owing to the increasing incidences of chronic respiratory diseases and the presence of key companies with robust infrastructures.
READ MORE

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Oxygen Conserving Devices Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Oxygen Conserving Devices Market

2.1.1 Main Objective of the Global Oxygen Conserving Devices Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER OXYGEN CONSERVING DEVICES INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL OXYGEN CONSERVING DEVICES MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT TYPE

8.1 Electronic Oxygen Conserver

8.2 Pneumatic Oxygen Conserver

8.3 Disposable Oxygen Conserver

8.4 Others

9 MARKET INSIGHTS BY IDENTIFICATION

9.1 Chronic Bronchitis

9.2 Emphysema

9.3 Sleep Apnea

9.4 Others

10 MARKET INSIGHTS BY END-USER

10.1 Hospitals & Clinics

10.2 Home Care

10.3 Others

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA OXYGEN CONSERVING DEVICES MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE OXYGEN CONSERVING DEVICES MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC OXYGEN CONSERVING DEVICES MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 South Korea

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD OXYGEN CONSERVING DEVICES MARKET

12 OXYGEN CONSERVING DEVICES MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 OXYGEN CONSERVING DEVICES MARKET OPPORTUNITIES

17 OXYGEN CONSERVING DEVICES MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Inogen Inc.

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1

19.1.6.2

19.1.7 Recent Developments

19.1.7.1

19.1.7.2

19.1.7.3

19.1.7.4

19.2 Chad Therapeutics

19.3 GCE Group

19.4 Precision Medical, Inc

19.5 DeVilbiss Healthcare

19.6 Medline Industries, Inc.

19.7 GF Health Products

19.8 Inovo, Inc

19.9 Essex Industries

19.10 Krober Medizintechnik

20 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Inogen Inc., Chad Therapeutics, GCE Group, Precision Medical, Inc, DeVilbiss Healthcare, Medline Industries, Inc., GF Health Products, Inovo, Inc, Essex Industries, and Krober Medizintechnik